MEGGLE Excipients

We’re happy to announce that MEGGLE Excipients, in collaboration with Barentz North America LLC, will be attending DCAT Week from March 17-20, 2025, in New York City! 🌆 📍 Meet us at the InterContinental New York Barclay and connect with: 🔹 Ruth Leinenbach – Director, MEGGLE Excipients Germany 🔹 Lewis Jackson – Managing Director, MEGGLE USA 📅 Let’s connect! Schedule a meeting with us here: info.excipients@meggle.com #DCATWeek2025 #PharmaceuticalExcipients #MEGGLEExcipients #BarentzNorthAmerica #PharmaInnovation #Lactose

📢 We are proud to announce that our colleague Ricarda C. Leister, Head of R&D at MEGGLE Excipients, will be speaking at the 𝟵𝘁𝗵 𝗜𝗠𝗣𝗨𝗥𝗜𝗧𝗜𝗘𝗦: 𝗚𝗲𝗻𝗼𝘁𝗼𝘅𝗶𝗰, 𝗡𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲 & 𝗕𝗲𝘆𝗼𝗻𝗱 𝗦𝘂𝗺𝗺𝗶𝘁 in Vienna & Online on 𝗔𝗽𝗿𝗶𝗹 𝟵-𝟭𝟬, 𝟮𝟬𝟮𝟱. 🔗 REGISTER https://lnkd.in/dnAeEm3x 🔗 More information: https://lnkd.in/dc7gqbdS 📍 Join us in Vienna or online! #impurities #genotoxic #mutagenic #nitrosamines #gtis #meggleexcipients #lactose

📢 We are proud to announce that our colleague Ricarda C. Leister, Head of R&D at MEGGLE Excipients, will be speaking at the 𝟵𝘁𝗵 𝗜𝗠𝗣𝗨𝗥𝗜𝗧𝗜𝗘𝗦: 𝗚𝗲𝗻𝗼𝘁𝗼𝘅𝗶𝗰, 𝗡𝗶𝘁𝗿𝗼𝘀𝗮𝗺𝗶𝗻𝗲 & 𝗕𝗲𝘆𝗼𝗻𝗱 𝗦𝘂𝗺𝗺𝗶𝘁 in Vienna & Online on 𝗔𝗽𝗿𝗶𝗹 𝟵-𝟭𝟬, 𝟮𝟬𝟮𝟱. 🔗 REGISTER https://lnkd.in/dnAeEm3x 🔗 More information: https://lnkd.in/dc7gqbdS 📍 Join us in Vienna or online! #impurities #genotoxic #mutagenic #nitrosamines #gtis #meggleexcipients #lactose

MEGGLE Excipients is pleased to announce a partnership with Brenntag Specialties for the exclusive distribution of our product portfolio in Benelux and Nordics.   This collaboration ensures that customers in these regions will have access to our extensive range of over 30 lactose-based excipients developed for various applications, including tableting, powder preparations and dry powder inhalation (DPI). More information about Brenntag | Pharma   Both MEGGLE and Brenntag are committed to supporting pharmaceutical innovation in Benelux and the Nordic countries, providing reliable excipient solutions for global healthcare. The collaboration aligns with MEGGLE’s mission to deliver superior excipients that empower customers to meet the highest quality standards in pharmaceutical manufacturing. More information under: https://lnkd.in/dpTqdhkg #brenntagspecialties #meggleexcipients #distributionagreement #benelux #nordics #brenntagpharma

🌟 Last Day at CPHI Middle East 2024 in Riyadh! The CPHI Middle East, held at the Riyadh Front Exhibition & Convention Center, is coming to a close today. Our colleague, Hani Calache, is still available today to discuss our innovative solutions and how we can support your business with high-quality functional excipients. 📩 Don’t miss the chance to connect with Hani before the event wraps up.

🤝 𝗠𝗘𝗚𝗚𝗟𝗘 𝗮𝘁 𝗗𝗗𝗟 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗘𝗱𝗶𝗻𝗯𝘂𝗿𝗴𝗵! We’re thrilled to participate at the Drug Delivery to the Lungs (DDL) Conference in Edinburgh, Scotland! 🌟 Meet the Team: 👨🔬 Dr. Rebekka Spellerberg, Global Application Manager – Business Unit Excipients 👨🔬 Tristan Mul, Business Development Manager – Inhalation Excipients 💡 Explore how our premium lactose grades can enhance your DPI formulations and support the development of cutting-edge inhalation therapies. 📍 Where: DDL Edinburgh 2024, Edinburgh International Conference Centre at 𝗕𝗼𝗼𝘁𝗵 𝟭𝟴𝟳, Scotland 📅 When: from 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝟭–𝟭𝟯 Let’s connect, exchange ideas, and explore solutions tailored to meet the evolving needs of the DPI industry and discover how 𝗜𝗻𝗵𝗮𝗟𝗮𝗰® 𝟮𝟰𝟬 can elevate your DPI formulations. We look forward to seeing you there!

🤝 𝗠𝗘𝗚𝗚𝗟𝗘 𝗮𝘁 𝗗𝗗𝗟 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗘𝗱𝗶𝗻𝗯𝘂𝗿𝗴𝗵! We’re thrilled to announce the 𝗹𝗮𝘂𝗻𝗰𝗵 𝗼𝗳 𝗼𝘂𝗿 𝗻𝗲𝘄 𝘀𝗶𝗲𝘃𝗲𝗱 𝗗𝗣𝗜 𝗹𝗮𝗰𝘁𝗼𝘀𝗲 𝗜𝗻𝗵𝗮𝗟𝗮𝗰® 𝟮𝟰𝟬 at the Drug Delivery to the Lungs (DDL) Conference in Edinburgh, Scotland! Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟭𝟴𝟳 from 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝟭–𝟭𝟯 to discover how 𝗜𝗻𝗵𝗮𝗟𝗮𝗰® 𝟮𝟰𝟬 can elevate your DPI formulations. As a Gold Sponsor, we’ll showcase this exciting addition to our inhalative lactose portfolio, designed for optimized pulmonary and nasal drug delivery. #MEGGLE #InhaLac240 #DDL2024 #InhalationInnovation #DPI

🤝 𝗠𝗘𝗚𝗚𝗟𝗘 𝗮𝘁 𝗗𝗗𝗟 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗘𝗱𝗶𝗻𝗯𝘂𝗿𝗴𝗵! We’re thrilled to announce the 𝗹𝗮𝘂𝗻𝗰𝗵 𝗼𝗳 𝗼𝘂𝗿 𝗻𝗲𝘄 𝘀𝗶𝗲𝘃𝗲𝗱 𝗗𝗣𝗜 𝗹𝗮𝗰𝘁𝗼𝘀𝗲 𝗜𝗻𝗵𝗮𝗟𝗮𝗰® 𝟮𝟰𝟬 at the Drug Delivery to the Lungs (DDL) Conference in Edinburgh, Scotland! Visit us at 𝗕𝗼𝗼𝘁𝗵 𝟭𝟴𝟳 from 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝟭–𝟭𝟯 to discover how 𝗜𝗻𝗵𝗮𝗟𝗮𝗰® 𝟮𝟰𝟬 can elevate your DPI formulations. As a Gold Sponsor, we’ll showcase this exciting addition to our inhalative lactose portfolio, designed for optimized pulmonary and nasal drug delivery. #MEGGLE #InhaLac240 #DDL2024 #InhalationInnovation #DPI

🎉 Celebrating 51 Years of Partnership with FARAVELLI Group 🎉 We are proud to celebrate over five decades of collaboration with Giusto Faravelli SpA, our exclusive distribution partner in Italy since 1973. A heartfelt thank-you to the Faravelli team for their dedication – we look forward to continuing this successful journey together.